Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.
Biol Blood Marrow Transplant
; 21(8): 1445-51, 2015 Aug.
Article
in En
| MEDLINE
| ID: mdl-25858810
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Transplantation Conditioning
/
Induction Chemotherapy
/
Bortezomib
/
Amyloidosis
/
Melphalan
/
Antineoplastic Agents
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Biol Blood Marrow Transplant
Journal subject:
HEMATOLOGIA
/
TRANSPLANTE
Year:
2015
Document type:
Article